Три комиссара, чей четырехлетний срок полномочий истек в этом году, также были повторно назначены в комиссию. CHM предоставляет министрам независимые экспертные консультации по вопросам безопасности, качества и эффективности лекарственных средств, а также способствует сбору и изучению информации, касающейся побочных реакций на лекарства для людей. Это консультативный вневедомственный государственный орган, спонсируемый Министерством здравоохранения и социального обеспечения.

Девять новых комиссаров:

• Профессор Тони Уильямс , профессор трансляционной медицины Саутгемптонского университета
• Профессор Дэвид Хант , заведующий кафедрой медицины нейровоспаления, старший научный сотрудник Wellcome Trust и почетный консультант по неврологии, Эдинбургский университет
• Professor David Dockrell, chair of infection medicine/director of the Centre for Inflammation Research, University of Edinburgh
• Dr Gerri Mortimore, associate professor in post-registration health care, University of Derby
• Professor Paul Dargan, consultant physician and clinical toxicologist at Guy’s and St Thomas’ NHS Foundation Trust and professor of clinical toxicology at King’s College London
• Dr Vanessa Raymont, senior clinical researcher, University of Oxford and R&D director and honorary consultant at Oxford Health NHS Foundation Trust
• Mrs Julia Cons, Independent Chair, National Individual Funding Request Panel for NHS England

• Professor David Moore, professor of Infectious Diseases & Tropical Medicine, London School of Hygiene & Tropical Medicine and Consultant Physician at The Hospital for Tropical Diseases, UCLH.

• Professor Rui Providencia, associate Professor, Institute of Health Informatics, UCL

Ms Susan Bradford, Professor Jamie Coleman and Dr Jamie Fraser, have also been reappointed to new terms on the CHM.

Professor Sir Munir Pirmohamed, Chair of the CHM, said:

I am pleased to welcome nine new Commissioners to the CHM, each bringing their own wealth of expertise and together enriching the independent advice that we provide to ministers.

I would also like to thank the existing commissioners, including those who have recently been reappointed, who continue to dedicate their time and expertise to our invaluable discussions on the safety and effectiveness of important medicines, on top of their day jobs.

Notes to editors

• The appointments will involve a time commitment of approximately 22 days per year, including 11 meetings and any ad-hoc meetings based on need. Remuneration for the roles will be at a rate of £325 per meeting
• These appointments are made in accordance with the Cabinet Office Code of Governance for Public Appointments. The regulation of public appointments against the requirements of this Code is carried out by the Commissioner for Public Appointments.
• The appointments are made on merit and political activity played no part in the decision process. However, in accordance with the Code, there is a requirement for appointees’ political activity (if any declared) to be made public. None have declared any political activity.
• More information on the Commission for Human Medicines.